Abstract:Preclinical and human studies indicate psilocybin may reduce perseverant maladaptive behaviors, including nicotine and alcohol seeking. Such studies in the opioid field are lacking, though opioids are involved in more >50% of overdose deaths. Psilocybin is an agonist at the serotonin 2A receptor (5-HT2AR), a well-documented target for modulation of drug seeking, and evidence suggests 5-HT2AR agonists may dampen motivation for opioids. We sought to investigate the therapeutic efficacy of psilocybin in mediating cessation of opioid use and maintenance of long-lasting abstinence from opioid seeking behavior in a rat model of heroin self-administration (SA). Psilocybin or 5-HT2AR antagonists ketanserin and volinanserin were administered systemically to rats prior to SA of 0.075 mg/kg/infusion of heroin, or relapse following forced abstinence. Psilocybin did not alter heroin taking, but a single exposure to 3.0 mg/kg psilocybin 4-24 hours prior to a relapse test blunted cue-induced heroin seeking. Conversely, 5-HT2AR antagonists exacerbated heroin relapse. To begin to elucidate mechanisms of psilocybin, drug-naive rats received psilocybin and/or ketanserin, and tissue was collected from the prefrontal cortex (PFC), a region critical for drug seeking and responsive to psilocybin, 24 hours later for RNA-sequencing. 3.0 mg/kg psilocybin regulated ~2-fold more genes in the PFC than 1.0 mg/kg, including genes involved in the cytoskeleton and cytokine signaling. Ketanserin blocked >90% of psilocybin-regulated genes, including the IL-17a cytokine receptor, Il17ra. Psychedelic compounds have reported anti-inflammatory properties, and therefore we performed a gene expression array to measure chemokine/cytokine molecules in the PFC of animals that displayed psilocybin-mediated inhibition of heroin seeking. Psilocybin regulated 4 genes, including Il17a, and a subset of genes correlated with relapse behavior. Selective inhibition of PFC IL-17a was sufficient to reduce heroin relapse. We conclude that psilocybin reduces heroin relapse and highlight IL-17a signaling as a potential downstream pathway of psilocybin that also reduces heroin seeking.

Resveratrol by elevating the SIRT1 BDNF, GDNF and PSD95 levels reduce heroin addiction related behaviors

Long-term Results after Deep Brain Stimulation of Nucleus Accumbens and the Anterior Limb of the Internal Capsule for Preventing Heroin Relapse: an Open-Label Pilot Study.

Inhibition of SIRT1 in the nucleus accumbens attenuates heroin addiction-related behavior by decreasing D1 neuronal autophagy

Activation of serotonin 5-HT2C receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice

Reversible Brain White Matter Microstructure Changes in Heroin Addicts: A Longitudinal Study

Sirtuin 1 Inhibitor EX527 Suppresses Morphine-Induced Behavioral Sensitization

Increased BDNF May Not Be Associated with Cognitive Impairment in Heroin-Dependent Patients

A Novel Role for the Histone Demethylase JMJD3 in Mediating Heroin-Induced Relapse-Like Behaviors

Metabolic Phenotype of Rats Exposed to Heroin and Potential Markers of Heroin Abuse

Therapeutic Effect of Implanted and Non-Invasive Vagus Nerve Stimulation on Heroin-Induced Anxiety

Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats

Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes among the Han Chinese.

Heroin Abuse Results in Shifted RNA Expression to Neurodegenerative Diseases and Attenuation of TNFα Signaling Pathway

Effects of Purine Nucleotide Administration on Purine Nucleotide Metabolism in Brains of Heroin-Dependent Rats

The Relationship Between Polymorphisms of BDNFOS and BDNF Genes and Heroin Addiction in the Han Chinese Population

The impact of heroin self-administration and environmental enrichment on ventral tegmental CRF1 receptor expression

Dopamine D1and D3Receptors Modulate Heroin-Induced Cognitive Impairment Through Opponent Actions in Mice

Increased Serum Brain-Derived Neurotrophic Factor Levels During Opiate Withdrawal.

Transcriptomics and Metabolomics Together Reveal the Underlying Mechanism of Heroin Hepatotoxicity

DBS of Nucleus Accumbens on Heroin Seeking Behaviors in Self-Administering Rats